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Introduction 48
Poly (methylvinylether-co-maleic anhydride) is a 1:1 copolymer of methyl vinyl ether 49 and maleic anhydride that is available in various grades, including the free acid form, 50 poly (methyl vinyl ether-co-maleic acid) (PMVE/MA) [1] . The low toxicity and 51 excellent biocompatibility of PMVE/MA have resulted in its widespread use 52 throughout the pharmaceutical and cosmetic industry [2, 3] . In particular, this 53 polymer has found use within toothpastes, mouthwashes, denture adhesives, 54 hairsprays, transdermal patches, periodontal drug delivery systems and within 55 stoma adhesive pastes [4] [5] [6] [7] [8] . 56 57 PMVE/MA has been reported to form adhesive interactions with mucin-coated 58 epithelial surfaces (termed mucoadhesion)[9-11] and, as a result, has been used as 59 a component of a range of biomedical implants where retention at the site of 60 application is important, e.g. as mucoadhesive nanospheres and microspheres, 61 mucoadhesive buccal tablets, mucoadhesive implants for application to the 62 periodontal pocket and microneedle transdermal systems. In such applications 63
The successful pharmaceutical and biomedical applications of PMVE/MA have 72 predominantly required the formation of networks with other polymers, most notably 73 poly(vinylpyrrolidone, PVP). For example in a series of publications, Jones et al. 74 described the formulation of networks of PMVE/MA and PVP that were designed for 75 use as implants within the oral cavity [6, 12, 13] . In these studies it was shown that 76 the rheological properties of the networks were engineered through modification of 77 both the ratio of PMVE/MA to PVP and polymer concentration. Other studies have 78 described the design of biomedical implants that involve the use of PMVE/MA in 79 association with other polymers. For example, Moreno et al. described the 80 formulation of thermosensitive hydrogels of PMVE/MA and Pluronic F127 that were 81 designed for the controlled release of proteins [16] . Whereas the combined use of 82 PMVE/MA and poloxamer 407 and hydroxypropylcellulose gels designed for the 83 treatment of oropharyngeal cancer has been described [17] . Most recently however 84
Jones et al. highlighted a significant concern regarding the use of interactive 85 polymer networks involving PMVE/MA.
The combination of PMVE/MA and 86 poly(vinyl alcohol) produced rheologically structured, mucoadhesive networks. 87
However, upon storage, the viscoelastic and mucoadhesive properties of the 88 networks were observed to significantly and detrimentally change thereby obviating 89 their use as biomedical implants. Conversely, there was no alteration of the 90 rheological properties of mono-polymeric PMVE/MA systems on storage [18] . The 91 use of binary polymeric networks involving PMVE/MA must therefore be treated with 92 extreme caution. 93 94 Despite the (growing) number of publications that describe the use of PMVE/MA-95 based platforms for biomedical applications (particularly for drug delivery 96 applications), there is a paucity of studies that have examined the physicochemical 97 properties of PMVE/MA regarding its suitability as a monopolymeric platform for 98 biomedical applications. This oversight is of scientific relevance for two reasons. 99
Firstly, without an understanding of the rheological and mucoadhesive properties of 100 PMVE/MA, the formulation of existing biomedical implants may not be optimal, with 101 detrimental consequences on their clinical usage. Secondly, full understanding and 102 knowledge of the rheological and mucoadhesive properties will offer possibilities for 103 the use of this polymer for an enhanced range of applications, e.g. as 104 pharmaceutical implants, drug delivery applications and as mucoadhesive, 105 viscoelastic implants designed to facilitate cataract removal [19] . 106 107 Therefore, this study aims to provide a comprehensive description of the rheological 108
properties of PMVE/MA and, for the first time, to specifically statistically examine the 109 relationship of these properties to the mucoadhesive properties. In particular the 110 generated data and the relationships between the various rheological and 111 7 All viscometric analyses of PMVE/MA solutions (0.2-0.6 g/dl) were performed using 151
Rheotek Ostwald U-tube viscometers sizes O-D. Solutions were added to the tube 152 via a pipette until the required level was reached. The U-tube was then placed into a 153
Rheotek water bath pre-set to 37°C±0.5°C and allowed to equilibrate for 15 minutes. 154
The time required for the fluid to fall a predetermined distance was measured and 155 used to calculate the kinematic viscosity (υ, mm 2 s -1 ) (Equation 1). 
Equation 6 182
Where: C is the polymer concentration and B is a constant 183
Continuous Shear Analysis. 185
Continuous shear (flow) analyses were performed at 37°C on the PMVE/MA (5-30% 186 w/w) systems using a TA systems AR2000 rheometer. Flow rheograms were 187 determined using either a 6cm or 4cm parallel stainless steel plate (gap size 1000 188 µm), the choice of geometry being determined by sample consistency. Samples to 189 be analysed were applied to the lower plate and allowed 15 minutes to equilibrate to 
Equation 8 200
Where: η is viscosity, η ∞ is the infinite shear viscosity, K is a structural relaxation 201 time, m is dimensionless and η 0 is the zero rate viscosity. 202
In each case, the flow properties of at least five replicates were determined. 203 204
Oscillatory Analysis. 205
Oscillatory analyses were performed at 37°C on PMVE/MA (5-30% w/w) systems 206 using a TA systems AR2000 rheometer, as previously reported by the authors [26] . 207 steel plate (gap size 1000 µm); the choice of geometry was determined by sample 209 consistency. Samples to be analysed were applied to the lower plate and allowed 210 15 minutes to equilibrate to negate any stresses induced during sample application. 211
For each sample, the linear viscoelastic region was determined via a stress sweep at 212 a fixed frequency. Once determined, a frequency sweep from 0.1 to 10Hz was 213 performed at a stress value selected from within the linear viscoelastic region. The 214 linear viscoelastic region was identified as the region in which the stress and the 215 strain were directly proportional and where the storage modulus (G`) remained 216 constant. From the resulting relationships between modulus and oscillatory 217 frequency, the storage modulus (G'), loss modulus (G"), dynamic viscosity (η') and 218 the loss tangent (tan δ) were then determined using the Rheology Advantage 219 software provided by T.A. Instruments. In each case the dynamic rheological 220
properties of at least five replicates were determined. 221 222
Mucoadhesion Testing 223
Mucoadhesion testing was conducted using a TA XT2 Texture Analyser in adhesion 224 mode as previously reported by . In brief, 400mg mucin discs 225 were manufactured using a 13mm IR press using a force of 10 tonnes for a period of 226 one minute. The discs were then attached to the end of a 10mm diameter 227 polycarbonate probe via double sided adhesive tape. Samples to be analysed were 228 transferred into a three-sided mould with mucoadhesion testing being determined at 229 37 o C. Prior to testing, samples were stored in sealed sample vials incubated at 37 o C 230 for 24hrs. Before testing, the disc was pre-wetted with 5% mucin solution with 231 excess being removed via blotting. A downward force of 0.1N was applied to the polymer platform, held for 30 seconds before being removed at a speed of 10mms -1 . 233
Mucoadhesion, determined as the force required to detach the polymer platform 234 from the mucin disc, of each formulation was obtained from five replicates 235 measurements. of polymer chains [45] . The presence of various ions however can cause shielding of 405 the negatively charged carboxylate groups resulting in a reduction in the repulsion 406 between polymer chains, decreasing formulation viscosity and elasticity [46] . The 407 net effect of this shielding effect that was apparent in this study was gels that had 408 been neutralised by sodium hydroxide exhibited lower elasticity than their organic 409 amine neutralised counterparts. This is apparent from the greater magnitude of the 410 storage modulus, the lower loss tangent values, the lower gel strength and the lower 411 crossover frequency of TEA-neutralised PMVE/MA gels, as depicted in Table 3 . 
Mucoadhesion of PMVE/MA Gels 430
The effects of polymer concentration and neutralisation/type of neutralising agent on 431 the mucoadhesive properties are presented in Table 3 . The mucoadhesive method 432 employed in this study has been frequently reported and is accepted as a model 433 which reliably characterises the interaction between mucin and polymeric 434 platforms[9, 50, 51]. One benefit of this test is the ability to quantify the force (or 435 work) required to break the adhesive bond between the polymer platform and the 436 mucin substrate and therefore the mucoadhesive properties of polymeric platforms 437 may be effectively compared. Polymer concentration and neutralisation/neutraliser 438 type significantly affected mucoadhesion, with a statistical interaction between 439 concentration and neutraliser being identified. In this, the dependency of polymer 440 concentration on mucoadhesion was greater for TEA neutralised systems than for 441 NaOH neutralised systems.
The mucoadhesive properties of un-neutralised 442 PMVE/MA systems could not be measured using this technique however, given the 443 ability of the method to reliably measure forces of detachment that are relevant to in properties of these systems are negligible. The mucoadhesive properties of 446 PMVE/MA systems significantly increased with increasing polymer concentration 447 and were greater for TEA-neutralised gels than for their NaOH-neutralised 448 counterparts. The mucoadhesive properties of neutralised PMVE/MA gels (15-30% 449 w/w) were substantial and greatly exceeded those of mucoadhesive implants that 450 have reported to be successfully retained in vivo within the periodontal pocket [29] . 451 Furthermore, given the wide range of polymer concentrations associated with these 452 enhanced mucoadhesive properties, it is expected that the retention of formulations 453 in vivo, e.g. within the periodontal pocket, would be resistant to dilution from 454 biological fluids. Given both the wide range of concentrations that exhibited 455 mucoadhesive properties and the magnitudes of mucoadhesion exhibited, these 456 mono-polymeric platforms would the expected to offer prolonged retention in vivo. 457 This is the first report that suggests this role for mono-polymeric PMVE/MA 458 platforms. 459 460
Statistical Modelling of the Relationship between Mucoadhesion and 461
Rheological Properties of PMVE/MA Gels 462
Within this study a series of statistical methods has been employed to ensure that 463 the effects of primary factors on the various rheological properties were fully 464 ascertained within a factorial experimental design. However, importantly, this study 465 additionally examined statistical interactions between the primary factors and 466 explained these within the context of the physicochemical properties of the gel 467 platforms. In so doing, a unique insight into the polymer state was derived. A key 468 task of this manuscript was to understand the relationship between the various 469 polymeric variables and mucoadhesion, a relationship that has not been fully described in the scientific literature to date. This study therefore described the 471 application of multiple linear regression to model the relationships between the 472 various variables with mucoadhesion, a parameter that is indicative of retention in 473 vivo. Accordingly, using a general linear model three major variables were observed 474 to affect mucoadhesion, namely polymer concentration, pH and the type of 475 neutralising agent. There were strong statistical interactions between these 476 variables and their effects on mucoadhesion. In these, the effect of polymer 477 concentration on mucoadhesion was significantly greater in gels neutralised with 478 TEA than in gels neutralised using NaOH. Similarly there was an interaction 479 between the pH and polymer concentration on mucoadhesion in which polymer 480 concentration exhibited a significantly greater effect on the mucoadhesion of 481 PMVE/MA gels when neutralised. To understand these relationships further 482 stepwise multiple regression analysis between the viscoelastic parameters and 483 mucoadhesion was performed. Unsurprisingly, the correlation matrix identified 484 strong relationships between the various viscoelastic properties and therefore the 485 multiple regression analysis was simplified by considering the effect of storage 486 modulus on the mucoadhesive properties of neutralised PMVE/MA platforms over a 487 range of different oscillatory frequencies. At each frequency examined there was a 488 strong relationship between storage modulus and mucoadhesion (r>0.98). 489
Furthermore the relationship between polymer concentration and mucoadhesion 490
was linear (r>0.99 for TEA neutralised gels, r>0.98 for NaOH neutralised gels and 491 0.94 for the overall effect combining both types of neutralisation). These results 492 have enabled a re-imagination of the roles of polymer viscoelasticity, concentration 493 and neutralisation on mucoadhesion. The process of mucoadhesion is understood 494 to be complex, with a number of physicochemical properties being reported to 495 contribute to this phenomenon including polymer molecular weight, polymer polymer and the charge on these groups [9, 54] . In this study the contribution of 498 polymer molecular weight and the type of functional group were constant across all 499 polymer platforms; however, the contributions of charge on the groups and polymer 500 concentration on mucoadhesion may be considered. Interestingly, there has been 501 little attention paid to the relationships between the aforementioned properties, 502 polymer viscoelasticity and mucoadhesion. This study has addressed this paucity 503 of information. Mucoadhesion involves an adhesive interaction between a polymeric 504 platform and mucin, facilitated through specific (hydrogen) bond formation [9] . In 505 principal, this interaction should be enhanced whenever the functional groups in 506 both polymers are unionised however this study has clearly shown that ionisation, 507 facilitated through neutralisation of the carboxylate groups of PMVE/MA resulted in 508 both marked and enhanced mucoadhesion. Notably, whilst the degree of polymer 509 ionisation affected mucoadhesion, the contribution of polymer viscoelasticity was 510 dominant, as defined within the statistical model. Thus, at identical levels of 511 ionisation the role of neutralising agent on the mucoadhesive and viscoelastic 512
properties was significant. Neutralisation with TEA resulted in a greater expansion of 513 the polymer chains through charge repulsion than in platforms similarly neutralised 514 using NaOH; the difference being accredited to charge shielding of the ionised 515 carboxylate groups with the sodium counterion. At pH 7.4 the degree of ionisation 516 of PMVE/MA was circa 99% and therefore, whilst there were differences in shielding 517 of charge in the two neutralised, both systems exhibited predominantly anionic 518
properties. With reference to the observed (strong) correlations between polymer 519 viscoelasticity and mucoadhesion, this study has highlighted that the dominant 520 factor that contributes to mucoadhesion is polymer viscoelasticity. Thus, as the 521 elastic properties of PMVE/MA are increased, the mucoadhesion increased, notably 522 in a linear fashion. Whilst not observed in this study, an upper limit in PMVE/MA 523 concentration would be expected beyond which no further increase in mucoadhesion is observed. In this scenario, the polymer interactions within 525 PMVE/MA would predominate thereby reducing the likelihood of adhesive 526
interactions with mucin. It should be clearly stated that, through the application of 527 statistical modelling, this study has clearly defined the dominant role of polymer 528 viscoelasticity on mucoadhesion, a conclusion that has not been directly defined in 529 previous studies. These observations explain, at least in part, the mucoadhesive 530
properties of non-charged polymers, e.g. cellulose ethers [9] . 531 532
3.5.
Re-defining the clinical opportunities for PMVE/MA Gels 533
Despite the use of PMVE/MA as a component within mucoadhesive platforms, there 534 has been limited use of this polymer as a single component system. Historically, 535 this may be related, at least in part, to the limited viscosity enhancement per unit 536 mass of polymer associated with this polymer (and the associated commercial cost). 537
Alteration of the concentration of PMVE/MA and/or neutralisation enhanced the 538 viscoelastic properties of the polymer platform and, in so doing, facilitated 539 enhanced mucoadhesion. Within the clinical domain, it is important that the 540 administration of implants is both not compromised by viscosity (associated with 541 increased polymer concentration) and is retained at the proposed site of 542 administration, the latter being facilitated by enhanced viscoelasticity (and polymer 543 concentration). Therefore a compromise is required between these two phenomena. 544
There is published evidence that clarifies the key rheological properties of gel 545 systems that have been successfully employed in vivo as implants for the treatment 546 of oral diseases, a potential application for the PMVE/MA systems under current 547 examination [29, 53, 55] . For example in these systems the storage modulus (at 548 circa 10Hz) and zero shear rate viscosity of a platform that was successfully applied to and retained within the periodontal pocket using a periodontal syringe were circa 550 3.5kPa and 2.6kPa.s, respectively. Accordingly, PVME/MA 30% w/w, TEA 551 neutralised gels, despite their excellent mucoadhesive properties would be 552 inappropriate for delivery using a periodontal syringe, however in applications 553 involving application of the gel to the site of action directly from a standard 554 container (e.g. using an applicator or manually), this would not be as important. It 555 should be noted that the rheological and mucoadhesive properties of the polymeric 556 platforms described in this study would be suitable for other pharmaceutical and 557 biomedical applications. For example, modification of the polymer concentration 558 will enable the rheological and mucoadhesive properties of PMVE/MA gels to be 559 engineered that are suitable for use as ophthalmic viscosurgical devices during 560 phacoemulsification [19] or for vaginal drug delivery applications [51] . Finally, it is 561 important to reiterate that by selection of polymer concentration and neutraliser type, 562 PMVE/MA gels may be prepared that offer comparable rheological and 563 mucoadhesive properties to multicomponent polymeric platforms that have been 564 successful clinically [29, 53] . This is important as it will obviate potential issues with 565 rheological ageing (structuring or destructuring) upon storage of multicomponent 566 systems. 567 568
Conclusions 569
In this study the rheological and mucoadhesive properties of aqueous PMVE/MA 570 platforms have been comprehensively characterised to establish their potential 571 suitability for biomedical and pharmaceutical applications. To address this issue, 572 the contributions of polymer concentration, pH and type of neutralising agent to the 573 viscoelastic and mucoadhesive properties were statistically modelled.
The 574 application of multiple linear regression analysis enabled the specific relationships 575 between the viscoelastic and mucoadhesive properties to be explicitly defined, a 576 feature that has yet to receive sufficient attention within the scientific literature. This 577 study uniquely identified the dominant contribution of polymer viscoelasticity on 578 mucoadhesion, an outcome that may be employed to rationally design 579 mucoadhesive platforms. Manipulation of both the rheological (flow and oscillatory 580 rheometry) and mucoadhesive properties was performed by changing both polymer 581 The relationship between modulus (storage and loss) and frequency 610 for PMVE/MA platforms that have been neutralised using NaOH. Figure 3 (a) relates 611 to PMVE/MA 5% w/w (circles), PMVE/MA 10% w/w (squares) and PMVE/MA 15% 612 w/w (diamonds). Figure 3 
